Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 196,576 | 255,841 | 79,381 | 86,218 | 74,386 |
| Receivables | 36,752 | 25,508 | 29,941 | 18,125 | 16,202 |
| Inventories | 8,156 | 9,292 | 9,624 | 11,818 | 12,852 |
| TOTAL | $245,506 | $295,480 | $123,841 | $118,503 | $110,396 |
| Non-Current Assets | |||||
| PPE Net | 2,412 | 2,426 | 2,519 | 2,611 | 2,704 |
| Investments And Advances | 29,451 | 18,707 | 17,660 | 0 | 0 |
| Intangibles | 25,510 | 26,479 | 27,605 | 28,670 | 29,734 |
| Other Non-Current Assets | 13,836 | 13,782 | 13,923 | 31,623 | 17,061 |
| TOTAL | $71,209 | $61,394 | $61,707 | $62,904 | $49,499 |
| Total Assets | $316,715 | $356,874 | $185,548 | $181,407 | $159,895 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 3,750 |
| Accounts payable and accrued liabilities | 49,325 | 92,986 | 47,125 | 45,171 | 48,576 |
| Other current liabilities | 268 | 268 | 136 | 137 | 2,071 |
| TOTAL | $62,018 | $103,393 | $49,744 | $54,067 | $57,521 |
| Non-Current Liabilities | |||||
| Long Term Debt | 34,602 | 36,878 | 52,417 | 47,774 | 50,026 |
| Other Non-Current Liabilities | 12,939 | -12,560 | 22,664 | 11,404 | 42,105 |
| TOTAL | $48,611 | $51,107 | $73,621 | $62,155 | $64,991 |
| Total Liabilities | $110,629 | $154,500 | $123,365 | $116,222 | $122,512 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,351 | 33,219 | 32,203 | 31,038 | 29,755 |
| Common Shares | 33 | 33 | 31 | 31 | 30 |
| Retained earnings | -624,147 | -623,679 | -734,052 | -730,115 | -735,965 |
| Other shareholders' equity | 41,946 | 40,166 | 12,310 | 9,323 | -6,541 |
| TOTAL | $206,086 | $202,374 | $62,183 | $65,185 | $37,383 |
| Total Liabilities And Equity | $316,715 | $356,874 | $185,548 | $181,407 | $159,895 |